Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2021 - 01 - 13 save search
Genprex Achieves Major Manufacturing Milestone for REQORSA™ Immunogene Therapy for Upcoming Trials to Treat Non-Small Cell Lung Cancer
Published: 2021-01-13 (Crawled : 23:00) - biospace.com/
GNPX | $2.21 -4.33% 6.77% 20K
|
Health Technology
|
| O: 4.79%
H: 2.79%
C: -1.02%
gene therapy therapy cancer lung cancer trial milestone
Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts
Published: 2021-01-13 (Crawled : 15:00) - biospace.com/
ZCMD | $1.52 -11.63% -10.61% 200K
|
Commercial Services
|
| O: -1.07%
H: 4.86%
C: 2.7%
cancer liver treatment diagnostic
FDA Grants Hoth Therapeutics Pre-IND Meeting Regarding Proposed Drug Development Plan for HT-001 Treatment for Cancer Patients
Published: 2021-01-13 (Crawled : 15:00) - biospace.com/
HOTH | $1.17 -1.68% 1.2% 17K
|
Health Technology
|
| O: 5.8%
H: 1.69%
C: -8.02%
cancer fda drug treatment granted grant
ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer
Published: 2021-01-13 (Crawled : 15:00) - biospace.com/
EPIX | $6.25 -2.34% -0.31% 41K
|
Health Technology
|
| O: 1.98%
H: 11.88%
C: 9.45%
collaboration cancer prostate cancer pharma
UroGen Pharma and MD Anderson Announce Strategic Research Collaboration to Advance Investigational Treatment for High-Grade Bladder Cancer
Published: 2021-01-13 (Crawled : 14:00) - biospace.com/
URGN | $14.21 -2.2% -2.04% 97K
|
Health Technology
|
| O: -0.21%
H: 0.57%
C: -3.38%
collaboration cancer research treatment pharma bladder
Salarius Pharmaceuticals Receives Second Installment of $1.7 Million in Payments from the Cancer Prevention and Research Institute of Texas
Published: 2021-01-13 (Crawled : 13:00) - globenewswire.com
SLRX | $0.508 1.4% 1.18% 19K
|
Commercial Services
|
| O: 5.26%
H: 5.83%
C: -0.83%
cancer research
Janssen to Highlight Commitment to Lung Cancer Science and Innovation with Eight Data Presentations at the International Association for the Study of Lung Cancer's 2020 World Conference on Lung Cancer
Published: 2021-01-12 (Crawled : 00:11) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.06%
H: 0.14%
C: -0.21%
cancer lung cancer
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.